News
Premier, Inc. (PINC) Tops Q1 Earnings and Revenue Estimates
Premier, Inc. (PINC) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.34 per share a year ago. These
Viridian Therapeutics, Inc. (VRDN) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
The market expects Viridian Therapeutics, Inc. (VRDN) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This
Sky Harbour Group Corporation (SKYH) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
The market expects Sky Harbour Group Corporation (SKYH) to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended September 2025
SKYX Platforms Corp. (SKYX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when SKYX Platforms Corp. (SKYX) reports results for the quarter ended September 2025. While this widely-known
Will Plug Power (PLUG) Report Negative Q3 Earnings? What You Should Know
The market expects Plug Power (PLUG) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus
Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Wall Street expects a year-over-year increase in earnings on higher revenues when Ovid Therapeutics (OVID) reports results for the quarter ended September 2025. While this widely-known consensus
Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Orchestra BioMed Holdings, Inc. (OBIO) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known
Ondas Holdings Inc. (ONDS) Expected to Beat Earnings Estimates: Should You Buy?
The market expects Ondas Holdings Inc. (ONDS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known
Compared to Estimates, NNN REIT (NNN) Q3 Earnings: A Look at Key Metrics
For the quarter ended September 2025, NNN REIT (NNN) reported revenue of $229.77 million, up 5.3% over the same period last year. EPS came in at $0.86, compared to $0.53 in the year-ago quarter.
The
HIVE Digital Technologies (HIVE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Wall Street expects a year-over-year increase in earnings on higher revenues when HIVE Digital Technologies (HIVE) reports results for the quarter ended September 2025. While this widely-known
Fate Therapeutics (FATE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Fate Therapeutics (FATE) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus
Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?
Bolt Biotherapeutics, Inc. (BOLT) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known
Compared to Estimates, Hertz Global (HTZ) Q3 Earnings: A Look at Key Metrics
Hertz Global Holdings, Inc. (HTZ) reported $2.48 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 3.8%. EPS of $0.12 for the same period compares to
Marriott (MAR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended September 2025, Marriott International (MAR) reported revenue of $6.49 billion, up 3.7% over the same period last year. EPS came in at $2.47, compared to $2.26 in the year-ago
Opus Genetics, Inc. (IRD) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
The market expects Opus Genetics, Inc. (IRD) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known
Hamilton Lane (HLNE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended September 2025, Hamilton Lane (HLNE) reported revenue of $190.88 million, up 27.3% over the same period last year. EPS came in at $1.54, compared to $1.07 in the year-ago
Evolution Petroleum (EPM) Reports Next Week: What You Should Expect
Wall Street expects flat earnings compared to the year-ago quarter on lower revenues when Evolution Petroleum (EPM) reports results for the quarter ended September 2025. While this widely-known
Integral Ad Science (IAS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Integral Ad Science (IAS) reported $154.36 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 15.6%. EPS of $0.07 for the same period compares to
Here's What Key Metrics Tell Us About Pfizer (PFE) Q3 Earnings
For the quarter ended September 2025, Pfizer (PFE) reported revenue of $16.65 billion, down 5.9% over the same period last year. EPS came in at $0.87, compared to $1.06 in the year-ago quarter.
The
Analysts Estimate CAE (CAE) to Report a Decline in Earnings: What to Look Out for
CAE (CAE) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook gives a good
Bet on These 3 Retail REITs as the Sector Shows Renewed Strength
Implied Volatility Surging for A. O. Smith Stock Options
Investors in A. O. Smith Corporation AOS need to pay close attention to the stock based on moves in the options market lately. That is because the Jan. 16, 2026 $40.00 Call had some of the highest
Navitas Stock Declines 9% on Q3 Loss, Revenues Fall Y/Y
Navitas Semiconductor (NVTS) shares dropped 9% after reporting third-quarter 2025 results on Monday (Nov. 3). Navitas shares have appreciated 198.1% year to date, outperforming the broader Zacks
Best Momentum Stocks to Buy for Nov. 4
Here is a stock with buy rank and strong momentum characteristics for investors to consider today, Nov. 4:
Logitech International S.A. LOGI: This software-enabled hardware solutions company has a
Somnigroup International (SGI) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Shares of Somnigroup International (SGI) have been struggling lately and have lost 5.5% over the past two weeks. However, a hammer chart pattern was formed in its last trading session, which could


